Real-world experience of switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B: a retrospective study
Author:
Affiliation:
1. Department of Gastroenterology, Changhua Christian Hospital, Changhua, Taiwan
2. Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan
3. General Education Center, Chienkuo Technology University, Changhua, Taiwan
Abstract
Funder
Changhua Christian Hospital
Publisher
PeerJ
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience
Link
https://peerj.com/articles/12527.pdf
Reference23 articles.
1. 96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection;Agarwal;Journal of Hepatology,2018
2. Clinical characteristics of hepatitis b virus patients after switching to tenofovir alafenamide fumarate: a retrospective observational study;Alghamdi;Cureus,2020
3. Safety and effectiveness of tenofovir alafenamide in usual clinical practice confirms results of clinical trials: TARGET-HBV;Bernstein;Digestive Diseases and Sciences,2021
4. Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial;Buti;The Lancet Gastroenterology & Hepatology,2016
5. Tenofovir alafenamide for drug-resistant hepatitis B: a randomized trial for switching from tenofovir disoproxil fumarate;Byun;Clinical Gastroenterology and Hepatology,2021
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Improvement of hepatic fibrosis after tenofovir disoproxil fumarate switching to tenofovir alafenamide for three years;World Journal of Hepatology;2024-07-27
2. Long-Term Hepatitis B Surface Antigen Profile and Seroclearance Following Antiviral Treatment: A Single-Center, Real-World Cohort Study;Biomedicines;2023-11-03
3. Comparison of the side effects of antivirals in chronic hepatitis B patients: a single-center experience;Acta Gastro Enterologica Belgica;2022-12
4. Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in chronic hepatitis B patients—author's reply;Alimentary Pharmacology & Therapeutics;2022-08-07
5. Editorial: changes in renal function and bone mineral density after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in patients with chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2022-08-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3